Cytek Biosciences, Inc. CTKB Other intangible assets—net
Other intangible assets—net at other companies
Other financials
Where this comes from
Reported directly by Cytek Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IntangibleAssetsNetExcludingGoodwill.
The official record: Cytek Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cytek Biosciences, Inc.'s other intangible assets—net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cytek Biosciences, Inc.'s other intangible assets—net?
- Cytek Biosciences, Inc. (CTKB) reported other intangible assets—net of $15.7M in Q1 2026.
- How has Cytek Biosciences, Inc.'s other intangible assets—net changed year-over-year?
- Cytek Biosciences, Inc.'s other intangible assets—net decreased by 19.2% year-over-year, from $19.43M to $15.7M.
- What is the long-term trend for Cytek Biosciences, Inc.'s other intangible assets—net?
- Over 5 years (2020 to 2025), Cytek Biosciences, Inc.'s other intangible assets—net has grown at a 127.8% compound annual growth rate (CAGR), from $274K to $16.82M.
- What does other intangible assets—net mean?
- This represents the net book value of identifiable non-physical assets such as patents, intellectual property, software licenses, and trademarks, excluding goodwill. These assets are vital for companies relying on proprietary technology and R&D. It captures the value of the company's competitive moat derived from its intellectual property portfolio.